Ares Management heads into its May 1 Q1 results with short sellers adding exposure but options traders actually stepping back from the defensive positioning that defined the past two months.
Short interest has climbed sharply heading into the print. It has risen 23% over the past month to 6.6% of the float — a meaningful build for an alternative asset manager. The pace has accelerated: shares short rose again on April 24, the latest reading, after a brief dip around April 9 during broad market volatility. Yet borrow conditions tell a calmer story. The cost to borrow is running at just under 0.49%, and utilization is at 12% — well below its 52-week high of 19%. The lending market is not stressed, which means new shorts face little friction but also no squeeze pressure.
The more striking move is in options. The put/call ratio has dropped sharply from its recent highs. In March and early April it ran well above 1.5; now it has eased to 1.12, almost 1.4 standard deviations below its 20-day average of 1.33. That is a notable rotation away from the defensive hedging that dominated options positioning for the past six weeks. The stock has also recovered: ARES is up about 5.5% over the past month to $112.18, despite giving back nearly 5.5% on the week. Close peers felt similar pressure — fell 6.8% on the week and dropped 5.8%, while and held up better. The broader group is clearly repricing the macro backdrop, not singling out Ares.
The analyst debate centres on how much the fundraising and monetisation slowdown has already been priced in. Bulls point to Ares' dominant direct-lending platform and a projected 20% AUM CAGR through 2027, arguing that the stock at roughly 17.7x earnings represents an entry point into a structurally growing private credit franchise. Bears counter that performance revenues remain pressured and that heavy reliance on performance-based compensation leaves earnings exposed to any renewed volatility. The weight of recent analyst moves sits firmly in one direction: targets have been cut across the board. Goldman Sachs trimmed to $131 from $165 on April 7, keeping a Buy. Morgan Stanley cut to $163 from $178 on April 21, at Equal-Weight. Barclays moved to $127 from $138 early in the month. The consensus mean of $144 still implies about 28% upside to the current price, but that gap has been compressing steadily. Notably, BMO has a target of $112 — right at the current price — which anchors the bear end of the range.
The May 1 print is therefore a test of whether Ares can demonstrate enough management-fee momentum and new capital commitments to justify rerating above a peer group that has already trimmed expectations, or whether a second consecutive post-earnings decline — after the stock dropped nearly 5% on the day following the last report — becomes the more dominant narrative.
See the live data behind this article on ORTEX.
Open ARES on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
